Study S000362

Real-world Weight Outcomes in Adults Treated With Semaglutide s.c. 1.0 mg or 1.7 mg for Weight Management: a Non-interventional Cohort Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07627074
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 237211
Start: 2026-05-12
Primary completion: 2026-06-15
Lead sponsor: Novo Nordisk A/S
Conditions: Overweight; Obesity
Interventions: DRUG:Semaglutide
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: OTHER:U1111-1338-2016

Registered primary outcomes

Change in body weight [From index date (day 0) to week 68 (day 476)]
Proportion of individuals achieving a clinically meaningful weight loss [From index date (day 0) to week 68 (day 476)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.